Genesis MedTech Group Raises Latest Round of Series B Financing

Genesis MedTech

Genesis MedTech Group, a Singapore-based medical device company, completed a Series B growth financing of undisclosed amount.

The round was led by General Atlantic with participation from CITIC Capital and the majority of shareholders from Series A. In conjunction with the funding, Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors.

The company intends to use the funds to drive the research and development of new products and the commercialization of existing products, as well as enable business expansion in emerging markets around the world.

Led by Warren Wang, Chairman and CEO, Genesis Medtech is a medical device company with a product portfolio that focuses on value segment multi-therapy medical device products for emerging markets with sales and distribution through its established commercial network.

Genesis MedTech Group covers the entire industry value chain of research and development, production, quality management, supply chain, marketing, and sales. To date, the company’s product portfolio includes surgical, neurovascular, peripheral vascular and cardiovascular products.